Riskpilot← Back to searchSign inGet full accessNike Medical AB
ABActiveOrg 5567496210Stallviksvägen 15Medical specialists activities · NACE 8622Est. 20080 employees
Revenue 2024
SEK 0
EBITDA margin
—
-2% vs 2023
Equity ratio
99.3%
Financial strength
Net profit 2024
SEK 8,7M
+33% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -228K | -2% |
| Net profit | SEK 8,7M | +33% |
| Total assets | SEK 16,5M | -66% |
| Equity | SEK 16,3M | +6% |
| Employees | 0 | — |
Legal name
Nike Medical AB
Org number
5567496210
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
16 januari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva läkar- konsultationer, föreläsningar, egen mottagningsverksamhet, sjukvårdsbemanning främst med gynekologisk inriktning och därmed förenlig verksamhet.
Address
Stallviksvägen 15
Phone
+46707721650
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 581 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 664 | −58 | −144 | −223 | −228 |
| Depreciation & amort. | −130 | −0 | −0 | −0 | −0 |
| EBIT | 4 534 | −58 | −144 | −223 | −228 |
| Net financials | — | −6 | −9 | −19 | 20 |
| Profit before tax | 7 314 | 12 474 | 7 927 | 8 232 | 10 945 |
| Tax | −1 581 | −2 591 | −1 642 | −1 698 | −2 281 |
| Net profit | 5 733 | 9 883 | 6 285 | 6 534 | 8 664 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 21 830 | 36 672 | 39 724 | 48 094 | 16 454 |
| Equity | 12 268 | 16 351 | 14 984 | 15 470 | 16 334 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 9 356 | 20 321 | 24 739 | 32 624 | 120 |
| Total debt | 9 356 | 20 321 | 24 739 | 32 624 | 120 |
EBITDA margin
-22800000.0%
This company
15.8%
Market median
-144303897% vs market
20202024
Equity ratio
99.3%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
53.0%
This company
18.4%
Market median
+188% vs market
20202024
Net profit margin
866400000.0%
This company
8.1%
Market median
+10696296196% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DF Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
LE Chief Auditor | Chief Auditor | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nike Medical AB 
Kvinnokliniken Sh ABBoard members of Nike Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| David Fredrik Lawenius | Chief Auditor | 0 companies |
| Saskia Maria Catharina Eklind | Chairman | 0 companies |
| Lars Anders Niklas Brywe | Deputy Board Member | 0 companies |
| Carl Viktor Eklind | Deputy Board Member | 0 companies |
| Anna Katarina Brywe | Board of Directors | 0 companies |